Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

5322 ARTÍCULOS , VIENDO DEL 1951 AL 1965

A mini-review of the role of vesicular glutamate transporters in Parkinson's disease

Zhao C, Wang C, Zhang H, Yan W.

Front Mol Neurosci. 2023 May 11;16:1118078. doi: 10.3389/fnmol.2023.1118078. eCollection 2023.

Olfactory Dysfunction in Parkinson's Disease, Its Functional and Neuroanatomical Correlates

Torres-Pasillas G, Chi-Castañeda D, Carrillo-Castilla P, Marín G, Hernández-Aguilar ME, Aranda-Abreu GE, Manzo J, García LI.

NeuroSci. 2023 Jun 5;4(2):134-151. doi: 10.3390/neurosci4020013. eCollection 2023 Jun.

Research progress on the kynurenine pathway in the prevention and treatment of Parkinson's disease

Chen P, Geng X.

J Enzyme Inhib Med Chem. 2023 Dec;38(1):2225800. doi: 10.1080/14756366.2023.2225800.

Research progress on gas signal molecular therapy for Parkinson's disease

Wang L, Dan Q, Xu B, Chen Y, Zheng T.

Open Life Sci. 2023 Aug 10;18(1):20220658. doi: 10.1515/biol-2022-0658. eCollection 2023.

Homocysteine, vitamin B metabolites, dopamine-substituting compounds, and symptomatology in Parkinson's disease: clinical and therapeutic considerations

Phokaewvarangkul O, Bhidayasiri R, Garcia-Ruiz P, Odin P, Riederer P, Müller T.

J Neural Transm (Vienna). 2023 Nov;130(11):1451-1462. doi: 10.1007/s00702-023-02684-9. Epub 2023 Aug 21.

Perspective on Cav-1 for its Potential as Newer Therapeutics for Parkinson's Disease

Singh G, Pushpa TK, Gupta SK, Srivastava S, Khatri DK, Singh SB.

CNS Neurol Disord Drug Targets. 2023;22(10):1429-1438. doi: 10.2174/1871527321666220909150406.

Gastrointestinal barriers to levodopa transport and absorption in Parkinson's disease

Leta V, Klingelhoefer L, Longardner K, Campagnolo M, Levent HÇ, Aureli F, Metta V, Bhidayasiri R, Chung-Faye G, Falup-Pecurariu C, Stocchi F, Jenner P, Warnecke T, Ray Chaudhuri K; International Parkinson and Movement Disorders Society Non-Motor Parkinson's Disease Study Group.

Eur J Neurol. 2023 May;30(5):1465-1480. doi: 10.1111/ene.15734. Epub 2023 Mar 7.

The Pharmacological Activity of Garlic (Allium sativum) in Parkinson's Disease: From Molecular Mechanisms to the Therapeutic Potential

Rakshit D, Nayak S, Kundu S, Angelopoulou E, Pyrgelis ES, Piperi C, Mishra A.

ACS Chem Neurosci. 2023 Mar 15;14(6):1033-1044. doi: 10.1021/acschemneuro.2c00789. Epub 2023 Mar 1.

Neurocognitive Psychiatric and Neuropsychological Alterations in Parkinson's Disease: A Basic and Clinical Approach

González-Usigli HA, Ortiz GG, Charles-Niño C, Mireles-Ramírez MA, Pacheco-Moisés FP, Torres-Mendoza BMG, Hernández-Cruz JJ, Delgado-Lara DLDC, Ramírez-Jirano LJ.

Brain Sci. 2023 Mar 18;13(3):508. doi: 10.3390/brainsci13030508.

Immunological Features of LRRK2 Function and Its Role in the Gut-Brain Axis Governing Parkinson's Disease

Peter I, Strober W.

J Parkinsons Dis. 2023;13(3):279-296. doi: 10.3233/JPD-230021.

Sex and gender differences in Alzheimer's disease, Parkinson's disease, and Amyotrophic Lateral Sclerosis: A narrative review

Nicoletti A, Baschi R, Cicero CE, Iacono S, Re VL, Luca A, Schirò G, Monastero R; Gender Neurology Study Group of the Italian Society of Neurology.

Mech Ageing Dev. 2023 Jun;212:111821. doi: 10.1016/j.mad.2023.111821. Epub 2023 Apr 29.

Glucose metabolism impairment in Parkinson's disease

Dai C, Tan C, Zhao L, Liang Y, Liu G, Liu H, Zhong Y, Liu Z, Mo L, Liu X, Chen L.

Brain Res Bull. 2023 Jul;199:110672. doi: 10.1016/j.brainresbull.2023.110672. Epub 2023 May 18.

Overview of the Impact of Pathogenic LRRK2 Mutations in Parkinson's Disease

Ito G, Utsunomiya-Tate N.

Biomolecules. 2023 May 16;13(5):845. doi: 10.3390/biom13050845.

Urolithin A in Health and Diseases: Prospects for Parkinson's Disease Management

Wojciechowska O, Kujawska M.

Antioxidants (Basel). 2023 Jul 24;12(7):1479. doi: 10.3390/antiox12071479.

Continuous subcutaneous levodopa-carbidopa for the treatment of advanced Parkinson's disease: is it an improvement on other delivery?

Doggrell SA.

Expert Opin Drug Deliv. 2023 Jul-Dec;20(9):1189-1199. doi: 10.1080/17425247.2023.2253146. Epub 2023 Sep 10.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias